Research and Development

The Research and Development team at Atsena Therapeutics is dedicated to advancing cutting-edge gene therapies aimed at reversing or preventing blindness. This team, composed of experts in translational research and assay development, collaborates to innovate and refine AAV-based therapies. By focusing on both clinical trials and preclinical assets, the team strives to address critical challenges in inherited retinal diseases and bring transformative treatments to patients in need.